Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
171 participants
OBSERVATIONAL
2007-04-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
NCT04918082
Predictive Clinical and Biological Parameters in Breast Cancer
NCT01521676
Healthy Lifestyles and Quality of Life in Women With Breast Cancer
NCT04379908
Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer
NCT01459003
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
NCT02791750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Within chemotherapy
30 couples, interviewed within chemotherapy (6 to 8 months after diagnosis)
interview
psychological, emotional, family and social parameters
within Herceptin
30 couples, within herceptin treatment (the first year after diagnosis)
interview
psychological, emotional, family and social parameters
within hormonotherapy
30 couples, within hormonotherapy (between 2 and 7 years after diagnosis)
interview
psychological, emotional, family and social parameters
without hormonotherapy
30 couples, did not received hormonotherapy (1 year after diagnosis)
interview
psychological, emotional, family and social parameters
end of treatment
30 couples, after end of treatments for patients who did received hormonotherapy (7 years after diagnosis)
interview
psychological, emotional, family and social parameters
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
interview
psychological, emotional, family and social parameters
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non metastatic breast cancer
* at least 6 months of relationship
Exclusion Criteria
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Oscar Lambret
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
François Baclesse Center
Caen, , France
Oscar Lambret Center
Lille, , France
Gustave Roussy Institut
Paris, , France
Hospital
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KALICOU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.